PH12012500557A1 - Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations - Google Patents

Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations

Info

Publication number
PH12012500557A1
PH12012500557A1 PH1/2012/500557A PH12012500557A PH12012500557A1 PH 12012500557 A1 PH12012500557 A1 PH 12012500557A1 PH 12012500557 A PH12012500557 A PH 12012500557A PH 12012500557 A1 PH12012500557 A1 PH 12012500557A1
Authority
PH
Philippines
Prior art keywords
pharmaceutical formulations
polymer compositions
proanthocyanidin polymer
producing
producing proanthocyanidin
Prior art date
Application number
PH1/2012/500557A
Inventor
Yingzhong Chen
John Chow
Suresh Mahadev Kadam
Mubeen Ahmed Khan
Vipin Kumar Pandey
Nitin Pradhan
Jonathan Tsang
Original Assignee
Glenmark Pharmaceuticals Ltd
Napo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Ltd, Napo Pharmaceuticals Inc filed Critical Glenmark Pharmaceuticals Ltd
Publication of PH12012500557A1 publication Critical patent/PH12012500557A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/38Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/47Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
PH1/2012/500557A 2009-08-26 2010-08-24 Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations PH12012500557A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1962MU2009 2009-08-26
PCT/IB2010/002060 WO2011024049A2 (en) 2009-08-26 2010-08-24 Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations

Publications (1)

Publication Number Publication Date
PH12012500557A1 true PH12012500557A1 (en) 2012-10-22

Family

ID=43337818

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2012/500557A PH12012500557A1 (en) 2009-08-26 2010-08-24 Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations

Country Status (4)

Country Link
EA (1) EA023814B1 (en)
PH (1) PH12012500557A1 (en)
WO (1) WO2011024049A2 (en)
ZA (1) ZA201202160B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2632550B1 (en) 2010-10-31 2017-05-03 Napo Pharmaceuticals, Inc. Methods and compositions for treating hiv-associated diarrhea
WO2012101008A1 (en) * 2011-01-27 2012-08-02 Glenmark Pharmaceuticals Limited Process for the production of proanthocyanidin polymeric composition
CN102210538A (en) * 2011-05-04 2011-10-12 惠州市欧野科技有限公司 Eaglewood powder and latex mixed pillow and manufacturing method thereof
RU2014124981A (en) * 2011-12-22 2016-02-10 Гленмарк Фармасьютикалс Лимитед NON-ENERGY-LUBRICANT PHARMACEUTICAL COMPOSITION CONTAINING CROPHELEMER
US9597298B2 (en) * 2013-06-07 2017-03-21 Remi Shrivastava Composition for topical application comprising glycerol and tannins
US20170095442A1 (en) * 2014-05-29 2017-04-06 Jaguar Animal Health, Inc. Methods of Treating Salmonella-Induced Diarrhea in Non-Human Animals
US20170119834A1 (en) * 2014-05-29 2017-05-04 Jaguar Animal Health, Inc. Methods of Treating Diarrhea in Adult Non-Human Animals
CN105294636B (en) * 2015-11-16 2018-11-27 大兴安岭林格贝寒带生物科技股份有限公司 A method of preparing glucosidase procyanidins
RU2639291C2 (en) * 2016-03-29 2017-12-20 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Method and composition of producing dry forms of blue anthocyanins
US12241877B2 (en) 2019-04-08 2025-03-04 R.P. Scherer Technologies, Llc Analytical method
US12440529B2 (en) * 2020-09-22 2025-10-14 Alphyn Biologics, Inc. Topical Croton lechleri compositions and their use in the treatment of a bacterial colonization or primary or secondary bacterial infection of an underlying skin disorder
US20220088102A1 (en) * 2020-09-22 2022-03-24 Alphyn Biologics, Llc Croton lechleri compositions and their use in the treatment of cystic fibrosis
CN117715651A (en) * 2021-02-25 2024-03-15 阿尔芬生物制品股份有限公司 Composition for treating topical skin bacterial skin disorders
JP2024508454A (en) * 2021-02-25 2024-02-27 アルフィン バイオロジックス、エルエルシー Composition for topical skin bacterial skin disease treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
EP0935417B1 (en) * 1996-10-16 2009-05-06 Napo Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
WO2000047062A2 (en) * 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
CA2657803C (en) * 2006-05-01 2019-01-08 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer

Also Published As

Publication number Publication date
WO2011024049A2 (en) 2011-03-03
WO2011024049A3 (en) 2011-05-19
EA023814B1 (en) 2016-07-29
ZA201202160B (en) 2013-08-28
WO2011024049A9 (en) 2013-04-25
EA201290098A1 (en) 2013-01-30

Similar Documents

Publication Publication Date Title
PH12012500556A1 (en) Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations
ZA201202160B (en) Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations
IL211008A0 (en) Thienopyrimidines for pharmaceutical compositions
GB0814695D0 (en) Pharmaceutical compositions
SG2014012405A (en) Pharmaceutical compositions
PL2323623T3 (en) Pharmaceutical compositions
ZA201107776B (en) Pharmaceutical composition
IL213545A0 (en) Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives
IL213546A0 (en) Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives
IL218937A0 (en) Pharmaceutical compositions comprising rivaroxaban
ZA201304127B (en) Oral compositions and method for producing thereof
IL206487A0 (en) Pharmaceutical compositions
EP2393361A4 (en) Pharmaceutical grade phthalazinediones, process for their preparation and pharmaceutical compositions containing them
ZA201304126B (en) Oral compositions and method for producing thereof
IL219018A0 (en) Pharmaceutical compositions
ZA201304088B (en) Oral compositions and method for producing thereof
EP2473168A4 (en) Pharmaceutical formulations for indibulin
GB0800659D0 (en) Pharmaceutical Compositions
GB0902428D0 (en) Pharmaceutical methods & compositions
GB0921139D0 (en) Pharmaceutical methods & compositions
GB0901241D0 (en) Pharmaceutical compositions
AU2009905147A0 (en) Pharmaceutical Compositions
HK1174530A (en) Pharmaceutical compositions
GB0806156D0 (en) Pharmaceutical compositions
GB0806283D0 (en) Pharmaceutical compositions